Document is current
Any future updates will be listed below
-
Authors
Mieguim Ngninpogni, Dominique
Ndo, Cyrille
Ntonga Akono, Patrick
Nguemo, Anicet
Nguepi, Amine
Metitsi, Danale Rosine
Tombi, Jeannette
Awono-Ambene, Parfait
Bilong Bilong, Charles Félix
-
Funding
Funding for this research was provided by:
Wellcome Trust (102543/Z/13/Z)
Royal Society of Tropical Medicine and Hygiene
- License Information
-
More Information
Article History
Received: 17 August 2020
Accepted: 7 December 2020
First Online: 2 January 2021
Ethics approval and consent to participate
: The study was approved by the Cameroonian National Ethical Committee for Research on Human Health (Statement No 2018/07/20/CE/NRERSH/SP). One week before the beginning of field activities, the population received a notice of information explaining the objectives, methodology, expected benefits and possible risks of the study. A consent form was sought from the head of households and for participants aged > 18 years for mosquito collection. They were given the opportunity to ask questions and they were informed that they are free to withdraw from the study at any time, without penalty or loss of benefits. At the end of each sampling period, all mosquito collectors were given anti-malaria prophylaxis based on artesunate/amodiaquine according to the national guide for malaria treatment.
: Not applicable.
: The authors declare they have no competing interests.
